$402.93
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The company is headquartered in Nashville, Tennessee and currently employs 230,000 full-time employees. The company went IPO on 2010-12-28. The firm provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. The company operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.
Country

US

CEO

Mr. Samuel Hazen

IPO date

2010

Employees

275,000

ISIN

US40412C1018

Key stats

Open

$411.38

Volume

1.05M

Market cap

$90.73B

Prev. close

$409.01

Impl / hst vl

-

Open interest

$0.00

$402.02

Day’s Range

$414.18

$356.89

52W Range

$556.52

Valuation

33
Valuation score
Overvalued
P/E
13.23
P/S
1.18
P/B
-
Current ratio
0.83
Debt / Equity
-
ROE
-
Gross margin
85.07%
Income growth
-13.74%
FCF growth
2.87

Jun

30

Dividends

The last payment date was Jun 30, 2026

Div. per Share

$0.78

Div. Yield

0.19%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 13 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$507.21
The top 23 analysts forecasts that 12-month price may increase by 25.88%, with a low of $376.94 and a high of $666.75
$376.94
Low
$507.21
Avg
$666.75
High
Current price

Earnings

Q1 ‘26 revenue
$19.11B
Q1 ‘26 net income
$1.62B
Revenue
Net income
Previous EPS
$7.15
Estimate EPS
$7.49
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply